PURE Bioscience, Inc. (PURE) Free cash flow 2017–2024
PURE Bioscience, Inc. (PURE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.6MFY2024 · since FY2017: -$5.0M → -$2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.6M | +23.7% |
| FY2023 | -$3.4M | -14.3% |
| FY2022 | -$2.9M | -139.9% |
| FY2021 | -$1.2M | -285.0% |
| FY2020 | $662,000 | +122.0% |
| FY2019 | -$3.0M | +26.5% |
| FY2018 | -$4.1M | +17.3% |
| FY2017 | -$5.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PURE financial trends
PURE RevenuePURE Net incomePURE Net marginPURE Gross profitPURE Gross marginPURE Operating incomePURE Operating marginPURE Operating cash flowPURE Capital expendituresPURE Return on equityPURE Stock buybacksPURE Dividends paidPURE Total assetsPURE Total liabilitiesPURE Shareholders’ equityPURE overview →